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sensitivity to P.P.D. (Field and Caspary, 1971a) yet negative
Mantoux reaction also has a high level of serum depressive
factor.
The inhibitory factor is not specific, in so far as M.S. or
sarcoid serum will also interfere with unrelated antigen-lympho-
cyte interaction. For example, serum (1:60) from a patient
with other neurological disease and two M.S. sera reduced a
mixed lymphocyte reaction by 23-1, 28-6, and 41 5°% res-
pectively. Likewise M.S. serum (1:60) reduced the interaction
between bovine serum albumin and lymphocytes in a case
of erythema nodosum by 54-8% and for egg albumen by
4810. A full account of these studies will be given else-
where, but it is already clear that the development of lymphocyte
sensitization (as indicated by the capacity to interact with a
particular antigen) seems to be associated with the appearance
in the serum of a depressant factor and that this factor is more
effective against its own lymphocytes than those from another
individual. In view of the many reports of depressive factor
referred to in the introduction, it may be that the present study
of M.S. and other neurological disease is but a special instance
of a general phenomenon-the simultaneous development of
lymphocyte responsiveness and a serum-mediated "damping
mechanism." If further studies support this view, then we have
another example of a biological "brake-accelerator" mechanism,
operating this time in immunological reactivity. The suppressor
element might indeed be the "feedback factor" postulated in
several modern schemata involving lymphocyte activity-for
example, that of Mackler (1971).
It is legitimate to speculate that disease may result from
imbalance between lymphocyte reactivity on the one hand and
suppressive activity of serum on the other, so that it would be
reasonable to attempt therapeutic control of lymphocyte
activity (either in positive or negative direction) by increasing or
reducing the suppressive factor. Thus autoimmune diseases (if
they exist) presumably result from a runaway activity of lympho-
cytes and might be treated by augmenting the level of suppressor
factor. On the other hand, where lymphocyte activity is being
held in check physiologically and where its greater exercise
might be beneficial-for example, in resistence to cancer-
it might be possible to eliminate or reduce suppressor activity.
As a first step it is necessary to isolate and characterize the
suppressor factor. Its relation to the factor isolated by Cooper-
band, Bondevik, Schmid, and Mannick (1968) is being explored,
but it is already clear that it occurs in the same x2-globulin
fraction in normal, M.S., and cancer serum.
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MEDICAL MEMORANDA
Muscle Fibrosis and Contractures
in a Pethidine Addict
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British Medical journal, 1971, 4, 532-533
Myopathy complicating intramuscular administration of some
drugs is well recognized. The repeated intramuscular injection
of chloroquine, for example, induces intense necrosis and
phagocytosis at the injection site (Aguayo and Hudgson,
1970). Pethidine is usually injected intramuscularly, and it is
perhaps surprising that there has been only one report of
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myopathy developing in those addicted to it (Aberfeld et al.,
1968). We believe that the case described here was of this
kind.
Case Report
The patient was a 60-year-old Indian who had emigrated to England
in 1968. When first seen in December 1968 he complained that
for 18 months he had experienced increasing difficulty in flexing
his elbows fully and for eight months a similar difficulty with his
knees. He had had a cholecystectomy in 1954 and a calculus
removed from the common bile duct in 1963. He was given
pethidine first in 1961 for biliary colic and he continued to inject
the drug with increasing frequency until the second laparotomy in
1963. After that he remained in hospital for three months, receiving
pethidine 100 mg every two or three days. On leaving hospital he
had continued to inject himself in steadily increasing doses up to
1,000 mg daily. At first he injected the drug only into the triceps
muscles, but in 1967 he developed an abscess in the left triceps and
began to inject the drug into the fronts of both thighs. When they
became "woody" he used the medial aspect of the thighs and the
buttocks. He did not sterilize the needles, which were about 3-7 cm
long, and changed them only every two or three weeks. Since
coming to England he had been persuaded by his son to stop the
drug, and apart from a feeling of restlessness and insomnia he had
suffered no untoward effects.
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On examination many needle marks were present on the lateral
aspects of both upper arms and of the thighs. Both triceps muscles
were indurated, particularly where there were most needle marks,
and the skin was also thickened. There was pronounced induration
of both thighs, particularly of the rectus femoris and vastus
medialis muscles and to a less extent of the vastus lateralis and
tensor fasciae latae, particularly on the right. There was severe
contracture of both triceps muscles, and elbow flexion was limited
to 85° on the left. There were also severe contractures of both
quadriceps, knee flexion being restricted to 450 on the right and
350 on the left. There was no demonstrable weakness of these
muscles. Triceps and knee jerks were absent but the other reflexes
were present. There were no sensory abnormalities in the extremi-
ties. There was moderate enlargement of the inguinal lymph nodes
but no other lymphadenopathy.
The serum adolase and aspartate and alanine transaminase levels
were all raised (10-7 mU/ml, 132 Karmen units, and 200 Karmen
units respectively) but the serum creatine kinase level was
normal. Radiographs of the arms and thighs showed no soft
tissue calcification. Considerable resistance was met in the right
triceps and rectus femoris muscles on introducing the needle
electrode for electromyography. In the triceps there were
occasional fibrillation potentials as well as spontaneous discharges of
high frequency which were abrupt in onset and termination. On
voluntary contraction brief polyphasic potentials of low amplitude
appeared, and the interference pattern on maximal effort was much
reduced in density and amplitude. Only distant activity of low
voltage was recorded in the quadriceps.
The most striking feature in sections of biopsy material from
the left rectus femoris and right triceps muscles was the presence
of gross, widespread interstitial fibrosis which had almost completely
Triceps biopsy. Severe loss of muscle fibres with fibrous tissue around
the remaining fibres which show excessive vanation in size and internal
nuclei. (Haematoxylin and eosin. x 208.)
replaced the muscle fibres in some areas, and broad bands of mature
collagen with a few atrophic muscle fibres distributed in a random
fashion were all that could be seen (Fig.). In all the fibrotic areas
the muscle fibres showed typical chronic myopathic changes-that
is, rounded fibres, some of which contained internal nuclei, con-
siderable variation in fibre diameter, and fibre splitting. Apart
from the areas into which the pethidine had presumably been
directly injected, however, the muscle fasciculi and individual fibres
were substantially normal apart from slight perimysial and endo-
mysial fibrosis. No other histological abnormalities were found and
histochemical study failed to show any evidence of selective fibre-
type atrophy or of any other metabolic disturbance.
The patient failed to complete a course of oral penicillamine,
given in the hope of arresting the fibrosis, but notwithstanding
made a remarkably good functional recovery with physiotherapy
alone. When last examined (August 1970) his right elbow could be
flexed to 140°, his left to 100', his right knee to 180', and his left
to 1100. He had not resumed injecting himself with pethidine, so
far as was known.
Comment
Aberfeld et al. (1968) described extensive induration of skin
and fibrosis of multiple limb muscles in a mother and
daughter who suffered from porphyria and had been addicted
to pethidine for periods of 12 and 5 years respectively. As
in the present case the pattem of muscle involvement did not
conform to that of any recognized myopathy, and the parts
involved were those accessible to self-administration of the
drug. The serum aldolase and creatinine kinase were raised
in one case and normal in the other. No electrical activity
could be recorded from the indurated areas of muscle in
either. The biopsy in their first case showed disorganization
of muscle, architecture with areas of connective tissue pro-
liferation, haemorrhage, and infiltration with mononuclear
cells. They believed that the muscle lesions were most likely
due to the combination of repeated needle trauma, chemical
irritation, and local infection. Certainly the production of focal
areas of muscle fibre destruction by hypodermic needles and
electromyographic needle electrodes has been shown in the
experimental animal (Engel, 1967; Hathaway et al., 1969).
It might be expected therefore that the repeated intra-
muscular injections in these patients would produce degenera-
tion of large numbers of muscle fibres. Disruption of the
sarcolemma and the endomystial sheaths of muscle fibres
would also render abortive any regenerative attempts, and
newly-formed muscle fibres would also be exposed to sub-
sequent needle trauma, contributing thereby to an overall loss.
Low grade infection probably played a part in the develop-
ment of the muscle lesions in the present patient. The possi-
bility that pethidine itself has a local myotoxic or sclerosing
action must also be considered. Though induration of skin
at the site of subcutaneous injection of pethidine is known to
occur (Goodman and Gilman, 1970) the effects of intra-
muscular injection of the drug have not been reported.
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